Mast Therapeutics (MSTX) CMO to Depart, Replacement Named
Tweet Send to a Friend
Mast Therapeutics, Inc. (NYSE: MSTX) announced today that Santosh Vetticaden, Chief Medical Officer and Senior Vice President, will be leaving ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE